Light therapy shows promise for Schizophrenia's toughest symptoms
NCT ID NCT05339347
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a non-invasive light therapy called photoneuromodulation in 30 adults with schizophrenia whose negative symptoms (like lack of motivation or social withdrawal) did not improve with standard treatments. Participants received either real or sham light sessions, then switched groups. The goal was to see if the light treatment could reduce these symptoms and improve quality of life.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Sao Paulo
São Paulo, São Paulo, Brazil
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new pill for schizophrenia pass its first human test?
- Can a new daily pill offer safer Long-Term control of schizophrenia?
- Can an Anti-Seizure drug quiet the brain and sharpen thinking in schizophrenia?
- Can a dissolving film tame agitation in schizophrenia?
- Can a phone app teach the brain to read social cues?
- Can a gentle brain current silence voices that medication Can't?